FDA Inspection 1273730 — Seattle Reproductive Medicine, Inc., P.S.
The FDA completed an inspection of Seattle Reproductive Medicine, Inc., P.S. on Jun 11, 2025 in Spokane Valley, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 11, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Spokane Valley, WA (United States)